arrow_back Back Filing freshness 10-Q Q3 FY2026 SEC EDGAR

MEDIFAST INC

MED
$12.75 ▼ -0.38 (-2.86%) at close
Consumer Staples ·Miscellaneous Food Preparations & Kindred Products ·USMiscellaneous Food Preparations & Kindred Products
69 Visible periods
33 Metrics
Peer-ranked Benchmarks
Price Chart
27
Health
Poor
Bearish
auto_awesome

Analytical Summary

MEDIFAST INC faces fundamental challenges with weakness in Profit Margin (%) and Operating Margin (%). The fundamentals warrant careful consideration of downside risks.

Market Cap $142.6M
Dividend Yield —
Revenue Growth -19.4% ↗
Op. Margin -26.9% ↘
ROIC -10.5% ↘
FCF / Share $0.26 ↗
Trailing P/E —
Price / Book 0.8x
FCF Yield 2.0%
Debt / Equity —
info Valuation on last close. End-of-day price, Nov 5, 2026.

69-Year Financial Trajectory

Quarterly
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$72.05M
↓ -19.4% —
Net Income Profit after all expenses
$-2.12M
↓ -174.9% —
Operating Margin Operating profit as % of sales
-26.9%
↓ -374.3% 22th
FCF / Share Free cash flow per share
$0.26
↑ +292.3% —
Long-Term Debt Long-term obligations
$0.00
— —
trending_up

Bullish Indicators

  • No bullish signals detected.
warning

Bearish Risks

  • Operating Margin (%)Operating Margin (%) is in the bottom quartile
  • Profit Margin (%)Profit Margin (%) is in the bottom quartile

Health Breakdown

Profitability ↓
23
Returns
35
Cash Quality
20

Dividend History

Dividend / share · sourced from SEC filings
$0.00 Latest / share

bar_chart Data from SEC EDGAR XBRL filings

Synced 5 days ago 18 years · 69 quarters